SUMMARY A large group of individuals with retinal disease were tested prospectively for contrast sensitivity by means of Arden gratings. A subgroup of 19 were also tested with the Nicolet automated television system. Individuals with macular or peripheral dystrophy showed a general reduction in contrast sensitivity as visual acuity decreased. The loss of contrast sensitivity was more prominent for high spatial frequencies (6.4 cycles per degree) than for low ones (0-2 cycles per degree). Similar results were obtained for patients with achromatopsia and congenital stationary night blindness. Patients with functional complaints, but no organic basis for decreased acuity, showed greater scatter in their test scores. The Nicolet results showed somewhat smoother curves, but were no more specific in separating normality from abnormality. Contrast sensitivity testing was not specific for the retinal disease entities considered, but may be useful in recording a degree of retinal damage and a degree of functional visual disability. Contrast sensitivity appeared to be reduced whenever acuity was reduced, so that a distinction could be made between patients having a loss of contrast beyond the expectations for their level of acuity and those in whom a loss of contrast simply corroborates the reduction of acuity.
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Snellen visual acuity testing is a relatively crude index of visual function, in so far as it measures resolution only with high contrast targets, since objects in the real world exhibit varying degrees of contrast (Fig. 2) . function. The total scores generally correlated with the levels of acuity in these subjects. All subjects perceived the coarsest grating, but those with reduced acuity could not perceive the finest one.
The patients with 'functional complaints' (Fig. 4 ) had a range of symptoms including poor acuity, sensitivity to glare, poor dark adaptation, and field constriction, but they showed no clear fundus abnormalities and had normal electrophysiological test results. the total grating scores for their eyes tended to increase as visual acuity decreased (with the exception of two questionably low scores in a patient who tested at 20/70 acuity), but the scatter was more pronounced and less predictable for each individual grating. (Fig. 5,  middle) showed, by either technique, a greater loss of high than low frequency sensitivity. The Arden results showed a severely abnormal contrast sensitivity for four of the six eyes, whereas only three of the six were severely abnormal by Nicolet testing. The patients with functional complaints (Fig. 5,  bottom) showed considerable scatter in their Arden results and had scores that sometimes fell in the borderline or elevated range. On testing with the Nicolet unit they showed more consistent curves, with predominant loss of sensitivity at higher frequencies.
Discussion
These data show clearly that contrast sensitivity is often subnormal in patients with retinal disease who still have relatively good acuity as measured on the Snellen chart. Conversely, some eyes with reduced central vision may show surprisingly good contrast sensitivity, especially for gratings of low spatial frequency. These general conclusions are consistent with earlier studies>"' and show as well that patterns of contrast deficiency are not very specific to one or another type of ocular pathology. For all of the retinal diseases tested the contrast sensitivity loss was most severe at higher spatial frequencies, and low frequencies were rarely compromised unless there was also a severe loss of visual acuity. The patients with functional complaints showed a scatter of data on contrast sensitivity testing, but this is consistent with their variable performance on other subjective tests.
These results do not mean that contrast sensitivity testing is of no value, of course. Contrast sensitivity testing may detect early organic damage before acuity is compromised; it may also help to follow (with coarse gratings) the progression of severe disease when acuity is already at a low level. Furthermore, the assessment of functional disability gives us understanding of how well adapted or badly adapted our patients are to visual tasks in the real world.
The Arden gratings have been criticised because of the manual procedure for uncovering the gratings. Arden'2 has claimed that the errors produced by operator variability are relatively minor, and this was our experience as well. The automated Nicolet system produced smoother curves than the Arden plates, but it did not appear any easier to separate normality from abnormality with the Nicolet data.
This study points out the importance of interpreting Fig. 6 . The straight line C represents the best actual scores achieved by our subjects at different levels of acuity: it extends from 2 standard deviations below the 20/20 mean to a score of 150 at a hypothetical acuity of 20/6400*. For comparison line D represents a theoretical limit beyond which no score can go: it begins near 20/100 where the spatial resolution (visual angle=5') approximates that of the *Snellen acuity of 20/20 is defined as the ability to resolve letters of 1' visual angle; thus, an acuity of 20/100 should be near the optical limit to perceive a grating of 5' per band, which is close to the spatial frequency of plate 7 (6-4 cpd). Indeed, our data show that some subjects with 20/100 could perceive the plate 7 grating, but none with 20/200 were able to perceive it. By extension 20/400 eyes would miss 3-2 cpd gratings, etc., and subjects with '20/6400' acuity would be unable to resolve plate 2 (0-2 cpd) and would therefore miss all the plates. .NO--. finest Arden grating (6.4 cpd). Any patient with a total score less than line D must be either anticipating the appearance of the gratings or responding falsely. Fig. 7 demonstrates that contrast sensitivity falls progressively with decreasing acuity, even for gratings whose spatial frequency is well within the subject's powers of resolution. For example, the 'best' score for 6.4 cpd plate 6 rises with even small losses of resolution (eg., 20/30 and 20/40) that do not come close to compromising perception of the grating. Similarly, when acuity is reduced to 20/200, the scores are elevated for all six plates even though the coarser gratings can still be easily resolved. This suggests that individuals with acuity less than 20/20 may be expected to show elevated Arden scores on the basis of their acuity alone, independently of other pathological concomitants. Only if the contrast deficit exceeds the normal (±2 SD) range that one would expect on the basis of acuity (i.e., the scores are above line A) can we conclude that contrast sensitivity is specifically or preferentially damaged. Contrast sensitivity better than expected on the basis of acuity (i.e., scores below line C) should raise doubts about the reliability or credibility of the subject. Fig. 7 IndividualArden gratingscores averagedfrom the 'best' eyes at each level ofvisual acuity (eyes whose total scoresfell between lines A and C in Fig. 6 ). The range of valuesfor normal subjects with 20120 acuity is shown ±2 standard deviations. comparison with either of these sets of data is difficult because the authors did not report the associated levels of visual acuity. Bodis-Wollner"5 stated that acuity alone does not predict the pattern of contrast loss. Our data confirm that statement in so far as the more pathological scores are concerned, but our data also suggest that acuity does predict a baseline or 'best' level of contrast sensitivity. One may criticise our conclusions because the data are derived from subjects with retinal or functional disease rather than from individuals with purely refractive loss of acuity. However, in view of the diversity of diagnoses and the spread of results in this study it does not seem unreasonable to postulate that the very best subjects at each level of acuity had contrast sensitivity scores near the optimum possible (regardless of whether the visual loss was retinal or refractive).
These results are relevant to the clinical application of contrast sensitivity testing. To the extent that a patient's low contrast sensitivity scores reflect only visual acuity, they add little to our diagnostic acumen; in fact they may give a misleading impression of specific pathology. If acuity effects are taken into account, then contrast sensitivity deficits beyond the level accounted for by acuity may have greater significance than previously appreciated.
